vancomycin has been researched along with Bone Diseases, Infectious in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bächli, M; Carrel, TP; Eigenmann, V; Englberger, L; Fuehrer, U; Gahl, B; Marschall, J; Reineke, D; Reineke, S; Roost, E; Seidl, C | 1 |
| Li, L; Wang, L; Wei, B; Yao, Q; Yuan, L; Zhang, X; Zhou, Z | 1 |
| Babcock, HM; Khair, HN; Liang, SY; Marschall, J; McDonald, JR | 1 |
| El-Ghannam, A; Marriott, I; Pacheco, H; Vedantham, K; Young, A | 1 |
| Ha, CW; Park, YB; Park, YG; Shaikh, AA | 1 |
| Desplaces, N; Dubée, V; Ducroquet, F; Guillet, S; Horellou, MH; Marmor, S; Zeller, V; Ziza, JM | 1 |
| Chen, C; Chen, Q; Ding, Z; Gao, J; Huang, G; Liu, G; Liu, Y; Ren, L | 1 |
| Feng, J; Hou, T; Li, Q; Xu, J; Zen, L | 1 |
| Paluch, D; Pielka, S; Rusiecki, M; Rutowski, R; Solski, L; Staniszewska-Kuś, J | 1 |
| Goldwirth, M; Krasin, E; Otremski, I | 1 |
| Bouza, E; Graninger, W; Schaison, G | 1 |
2 review(s) available for vancomycin and Bone Diseases, Infectious
| Article | Year |
|---|---|
[Vancomycin therapy in bone and joint infections--looking into the future].
Topics: Anti-Bacterial Agents; Bacterial Infections; Bone Diseases, Infectious; Cross Infection; Humans; Joint Diseases; Staphylococcal Infections; Vancomycin | 2000 |
Teicoplanin in the treatment of serious infection.
Topics: Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Child; Cross Infection; Drug Administration Schedule; Drug Resistance, Microbial; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Home Care Services; Humans; Intensive Care Units; Joint Diseases; Neutropenia; Staphylococcal Infections; Teicoplanin; Vancomycin | 2000 |
9 other study(ies) available for vancomycin and Bone Diseases, Infectious
| Article | Year |
|---|---|
Adding vancomycin to perioperative prophylaxis decreases deep sternal wound infections in high-risk cardiac surgery patients.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bone Diseases, Infectious; Cardiac Surgical Procedures; Cohort Studies; Female; Humans; Male; Middle Aged; Risk Factors; Sternum; Surgical Wound Infection; Vancomycin | 2018 |
Antimicrobial Activity of 3D-Printed Poly(ε-Caprolactone) (PCL) Composite Scaffolds Presenting Vancomycin-Loaded Polylactic Acid-Glycolic Acid (PLGA) Microspheres.
Topics: Animals; Anti-Infective Agents; Bone Diseases, Infectious; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Polyesters; Polylactic Acid-Polyglycolic Acid Copolymer; Printing, Three-Dimensional; Rabbits; Tissue Engineering; Tissue Scaffolds; Vancomycin | 2018 |
Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): a nested case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Case-Control Studies; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2014 |
Tissue engineering scaffold for sequential release of vancomycin and rhBMP2 to treat bone infections.
Topics: Animals; Anti-Bacterial Agents; Bone Diseases, Infectious; Bone Morphogenetic Protein 2; Cell Line; Delayed-Action Preparations; Humans; Mice; Recombinant Proteins; Staphylococcal Infections; Staphylococcus aureus; Tissue Engineering; Tissue Scaffolds; Vancomycin | 2014 |
Two-stage approach to primary TKA in infected arthritic knees using intraoperatively molded articulating cement spacers.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Biomechanical Phenomena; Bone Cements; Bone Diseases, Infectious; Debridement; Female; Humans; Infection Control; Knee Joint; Knee Prosthesis; Male; Middle Aged; Osteoarthritis, Knee; Prosthesis Design; Prosthesis-Related Infections; Radiography; Range of Motion, Articular; Recovery of Function; Sepsis; Streptomycin; Time Factors; Treatment Outcome; Vancomycin | 2014 |
Large Cohort Study of Central Venous Catheter Thrombosis during Intravenous Antibiotic Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Bacterial Infections; Bone Diseases, Infectious; C-Reactive Protein; Case-Control Studies; Catheterization, Central Venous; Central Venous Catheters; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Thrombosis; Vancomycin | 2016 |
A biodegradable antibiotic-eluting PLGA nanofiber-loaded deproteinized bone for treatment of infected rabbit bone defects.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Bacterial Load; Bone and Bones; Bone Diseases, Infectious; Bone Regeneration; Cattle; Chromatography, High Pressure Liquid; Drug Carriers; Drug Liberation; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Random Allocation; Tissue Scaffolds; Vancomycin | 2016 |
In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation.
Topics: Alginates; Animals; Anti-Bacterial Agents; Bone Diseases, Infectious; Cells, Immobilized; Drug Delivery Systems; Gels; Glucuronic Acid; Goats; Hexuronic Acids; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Osteogenesis; Vancomycin | 2008 |
[The bone reaction to the implantation of the corundum-vancomycin composite].
Topics: Aluminum Oxide; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Bone Diseases, Infectious; Ceramics; Drug Carriers; Female; Femur; Male; Rabbits; Time Factors; Vancomycin | 2004 |